[Congressional Record Volume 150, Number 86 (Monday, June 21, 2004)]
[Senate]
[Page S7102]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




              IN RECOGNITION OF ALAN MILBAUER'S RETIREMENT

 Mr. CARPER. Madam President, I pay tribute today to Alan 
Milbauer upon his retirement as vice president of public affairs for 
AstraZeneca. His dedication has won him the respect of coworkers and 
friends alike, along with the gratitude of many in our State. He has 
been, and remains, a trusted friend.
  A native of Brooklyn, NY, Alan was born on August 30, 1943, to 
Francis and Irving Milbauer. He received his early education in 
Brooklyn and went on to earn degrees in pharmacy and law at the 
University of Connecticut in 1965 and 1968, respectively.
  Alan has spent most of his career in the pharmaceutical industry, 
except for a brief experience in the field of consumer marketing 
research. He began his industry experience as attorney for the 
Pharmaceuticals Research and Manufacturers of America, PhRMA, before 
coming to Delaware and joining Zeneca Pharmaceuticals--then Atlas 
Chemicals--in 1969. In 1976, he was appointed director of regulatory 
affairs. He became vice president of planning in 1985 and vice 
president of marketing in 1991. Prior to the merger of Astra and 
Zeneca, Alan served as vice president of external affairs for Zeneca 
Pharmaceuticals.
  As a member of the U.S. AstraZeneca leadership team, Alan's 
responsibilities include Federal and State government affairs, 
corporate external communications, public relations and ally 
development, corporate and community affairs, and public policy. As a 
major international healthcare business engaged in the research, 
development, manufacturing and marketing of pharmaceuticals and 
healthcare services, Alan has provided strong leadership and served as 
a role model to many. According to friends, he has been described as 
the ``conscience'' for the company. He has long sought to ensure that 
AstraZeneca was mindful of its corporate responsibility to the 
community. Alan brought the human side to the corporate world. He also 
played a role in helping bring AstraZeneca's United States headquarters 
to Delaware during my years as Governor.
  Alan serves as a board director for the Delaware Theatre Company, 
Delaware Public Policy Institute, and is a trustee of the University of 
the Sciences in Philadelphia. He is also a member of the board of 
directors of the Vox Medical Center for Patient Education and Health 
Literacy, and is a member of the Connecticut Bar. Alan's leisure 
interests include travel, theater, reading, and playing golf.
  Alan and his wife of 37 years, Nancy, live in Wilmington, DE. They 
have three children, Karen, Stephen and Jennifer, and two 
grandchildren, twins Jacob and Rachel.
  Through Alan's efforts, he has made a real difference in the lives of 
thousands of individuals and enhanced the quality of life for our 
State. Upon his retirement, he will leave behind a legacy of commitment 
to public service for both his children and grandchildren and for 
others to follow. I thank him for the friendship that we share, and I 
congratulate him on a remarkable and distinguished career. I wish him 
and his family only the very best in all that lies ahead for each of 
them.

                          ____________________